OBJECTIVE: To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). DESIGN: Cross-sectional descriptive study within a multicenter, randomized clinical trial. PARTICIPANTS: Patients who developed CNV during CAPT follow-up. METHODS: Inclusion criteria for CAPT specified bilateral large drusen (>or=10 drusen at least 125 micro), visual acuity >or=20/40 in each eye, and age >or=50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 micro of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for >or=5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV. MAIN OUTCOME MEASURES: Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined. RESULTS:Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were <or=2 MPS disc areas. Visual acuity was >or=20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients. CONCLUSIONS: When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity.
RCT Entities:
OBJECTIVE: To describe the characteristics of incident choroidal neovascularization (CNV) in observed and treated eyes in the Complications of Age-related Macular Degeneration Prevention Trial (CAPT). DESIGN: Cross-sectional descriptive study within a multicenter, randomized clinical trial. PARTICIPANTS: Patients who developed CNV during CAPT follow-up. METHODS: Inclusion criteria for CAPT specified bilateral large drusen (>or=10 drusen at least 125 micro), visual acuity >or=20/40 in each eye, and age >or=50. Exclusion criteria included CNV and geographic atrophy >1 Macular Photocoagulation Study (MPS) disc area or within 500 micro of the foveal center. One eye of each person was selected randomly for low-intensity laser treatment and the contralateral eye was observed. Fluorescein angiography was performed at baseline, annually for >or=5 years, and whenever there were symptoms of CNV. Trained readers at the CAPT Photograph Reading Center assessed color stereo photographs and angiogram negatives to identify CNV. MAIN OUTCOME MEASURES: Choroidal neovascularization was classified by type (predominantly classic CNV, minimally classic CNV, occult only CNV, or scar), location, and area. Visual acuity was measured by certified examiners. Symmetry of characteristics between eyes of bilaterally affected patients was examined. RESULTS: Choroidal neovascularization developed in 282 eyes of 225 patients. At the time of detection, 192 (68%) of the lesions were occult only, 153 (54%) were subfoveal, and 157 (56%) were <or=2 MPS disc areas. Visual acuity was >or=20/40 in 123 (69%) of 179 eyes with visual acuity measured at the time of detection. Choroidal neovascularization developed in both eyes in 57 patients (25%) during CAPT follow-up. Lesions in eyes of bilaterally affected patients were no more similar to each other than affected eyes in 2 different patients. CONCLUSIONS: When patients are monitored closely, many CNV lesions can be detected outside of the fovea and when they are relatively small. Early detection may lead to improved long-term visual acuity.
Authors: Jessica N Leuschen; Stefanie G Schuman; Katrina P Winter; Michelle N McCall; Wai T Wong; Emily Y Chew; Thomas Hwang; Sunil Srivastava; Neeru Sarin; Traci Clemons; Molly Harrington; Cynthia A Toth Journal: Ophthalmology Date: 2012-09-08 Impact factor: 12.079
Authors: Agnieszka A Zuber; David E Robinson; Robert D Short; David A Steele; Jason D Whittle Journal: J Mater Sci Mater Med Date: 2014-02-04 Impact factor: 3.896
Authors: Muneeswar G Nittala; Yeunjoo E Song; Rebecca Sardell; Larry D Adams; Samuel Pan; Swetha B Velaga; Violet Horst; Debra Dana; Laura Caywood; Renee Laux; Denise Fuzzell; Sarada Fuzzell; William K Scott; Jessica N Cooke Bailey; Robert P Igo; Jonathan Haines; Margaret A Pericak-Vance; SriniVas R Sadda; Dwight Stambolian Journal: Retina Date: 2019-08 Impact factor: 3.975
Authors: Erica L Fletcher; Andrew I Jobling; Ursula Greferath; Samuel A Mills; Michelle Waugh; Tracy Ho; Robb U de Iongh; Joanna A Phipps; Kirstan A Vessey Journal: Optom Vis Sci Date: 2014-08 Impact factor: 1.973